Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Male circumcision and herpes simplex virus type 2 infection in female partners: A randomized trial in Rakai, Uganda
Journal of Infectious Diseases, Volume 205, No. 3, Year 2012
Notification
URL copied to clipboard!
Description
Male circumcision reduces acquisition of herpes simplex virus type 2 (HSV-2) in men. We assessed whether male circumcision reduces HSV-2 infection among female partners. HSV-2-negative, human immunodeficiency virus-negative female partners of 368 males who were and 372 males who were not randomized to receive male circumcision were enrolled. The incidence of HSV-2 infection among females over a period of 2 years was 6.09 cases per 100 person-years in the intervention arm and 6.32 cases per 100 person-years in the control arm (incidence rate ratio [IRR], 0.96 [95% confidence interval {CI},. 62-1.49]; P =. 87). Among female partners of HSV-2-positive males, the incidence of HSV-2 infection was 9.55 cases per 100 person-years in the intervention arm and 11.17 cases per 100 person-years in the control arm (IRR, 0.85 [95% CI,. 44-1.67]; P =. 62). Contrary to findings in males, male circumcision did not affect HSV-2 acquisition among female partners. © The Author 2011. Published by Oxford University Press on behalf of the Infectious.
Authors & Co-Authors
Tobian, Aaron A.R.
United States, Baltimore
Johns Hopkins University
United States, Baltimore
Johns Hopkins Bloomberg School of Public Health
Kigozi, Godfrey G.
Uganda, Kalisizo
Rakai Health Sciences Program
Redd, Andrew D.
United States, Bethesda
National Institute of Allergy and Infectious Diseases Niaid
Serwadda, David Musoke
Uganda, Kalisizo
Rakai Health Sciences Program
Uganda, Kampala
Makerere University
Kong, Xiangrong
United States, Baltimore
Johns Hopkins Bloomberg School of Public Health
Oliver, Amy E.
United States, Baltimore
School of Medicine
Nalugoda, Fred Kakaire
Uganda, Kalisizo
Rakai Health Sciences Program
Quinn, Thomas Charles
United States, Bethesda
National Institute of Allergy and Infectious Diseases Niaid
United States, Baltimore
School of Medicine
Gray, Ronald H.
United States, Baltimore
Johns Hopkins Bloomberg School of Public Health
Uganda, Kalisizo
Rakai Health Sciences Program
Wawer, Maria J.
United States, Baltimore
Johns Hopkins Bloomberg School of Public Health
Uganda, Kalisizo
Rakai Health Sciences Program
Statistics
Citations: 28
Authors: 10
Affiliations: 6
Identifiers
Doi:
10.1093/infdis/jir767
ISSN:
00221899
Study Design
Randomised Control Trial
Cohort Study
Study Locations
Uganda
Participants Gender
Male
Female